Pain, Nausa, Vomitting, Gastric bypass laparoscopic surgery.
Conditions
Interventions
Intervention 1: Intervention group: The first intervention group receives 0.75 mg of ketamine per kilogram of weight. The drug is administered as a single intravenous dose during surgery. Intervention
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Diagnosis of laparoscopic abdominal surgery (the patient or doctor has chosen laparoscopic gastric bypass for weight loss) Age over 18 years and under 65 years Informed consent to participate in the study Patients who are candidates for surgery under general anesthesia Patients who are candidates for laparoscopic gastric bypass surgery with a BMI above 40
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Upon entering recovery and every fifteen minutes until exiting recovery. Method of measurement: Pain measurement using the visual analogue scale method gives the necessary score according to the severity of the pain (0 means none, from 1 to 3 means mild, from 4 to 6 means moderate, from 7 to 10 means severe).;Nausa. Timepoint: Upon entering recovery and every fifteen minutes until exiting recovery. Method of measurement: Grades of nausea: 0 = no nausea1 =mild nausea, not requesting pharmacological rescue2 = nausea, requesting pharmacological rescue3 = nausea, resistant to pharmacological treatment.;Vomitting. Timepoint: Upon entering recovery and every fifteen minutes until exiting recovery. Method of measurement: Grades of vomiting:0 = no vomiting1 =vomiting, single event2 =vomiting, repeated events, requesting pharmacological rescue3 = vomiting, resistant to pharmacological treatment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNiloofar Jalalpour
Esfahan University of Medical Sciences
Outcome results
None listed